ACUS recommends inviting public participation in rulemaking even when agencies forgo notice and comment.

On May 12, 2025, the US Environmental Protection Agency (EPA) issued an interim final rule significantly extending the reporting deadlines for PFAS reporting under Section 8(a)(7) of the Toxic ...

CHICAGO Attorney General Kwame Raoul today, as part of a coalition of 19 attorneys general, submitted a comment letter ...

Watchdogs warn the U.S. Treasury’s rollback of transparency law could cripple efforts to fight money laundering and illicit ...

MSPB is generally responsible for adjudicating appeals on federal personnel cases. But without a board quorum, some specific actions at MSPB can't be finalized.

The U.S. Environmental Protection Agency (EPA) published an interim final rule on May 13, 2025, extending the reporting deadlines for its Per- and polyfluoroalkyl substances (PFAS) Reporting Rule ...

In 2021, HUD issued a rule requiring all grantees to certify their AFFH compliance before receiving federal funding. The office says the HUD’s new interim final rule cuts this requirement ...

“This interim final rule returns to the original understanding of what the statutory AFFH certification was prior to 1994 — a general commitment that grantees will take active steps to promote ...

acting DHS secretary Chad Wolf drafted an Interim Final Rule that required U.S. employers to file online the Form I-9 that the law requires them to fill out and keep on-site for every newly hired ...

One of the Biden administration’s final actions was releasing new export controls, commonly referred to as the AI Diffusion Rule. The regulations would impose new restrictions on selling certain ...

The Office of the Comptroller of the Currency (OCC) has released an interim final rule, reinstating its expedited review process for bank merger applications in the US. This move marks a policy ...

A bipartisan pair of senators introduced legislation to lower prescription drug prices by prohibiting pharmaceutical companies from selling drugs in the U.S. at higher prices than the ...